Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Sep 28;12(1):16166.
doi: 10.1038/s41598-022-20399-x.

Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis

Gauri Mukhiya et al. Sci Rep. .

Abstract

This study was performed to evaluate the outcome of endovascular intervention therapy for Budd-Chiari syndrome (BCS) and compare recanalization, transjugular intrahepatic portosystemic shunt (TIPS)/direct intrahepatic portosystemic shunt (DIPS), and combined procedure treatment. For the meta-analysis, 71 studies were identified by searching four databases. The individual studies' samples were used to calculate a confidence interval (CI 95%), and data were pooled using a fixed-effect model and random effect model. The pooled measure and an equal-weighted average rate were calculated in all participant studies. Heterogeneity between the studies was assessed with I2, and T2 tests, and publication bias was estimated using Egger's regression test. A total of 4,407 BCS patients had undergone an endovascular intervention procedure. The pooled results were 98.9% (95% CI 97.8‒98.9%) for a technical success operation, and 96.9% (95% CI 94.9‒98.9%) for a clinical success operation. The re-intervention rate after the initial intervention procedure was 18.9% (95% CI 14.7‒22.9%), and the survival rates at 1 and 5 years after the initial intervention procedure were 98.9% (95% CI 96.8‒98.9%) and 94.9% (95% CI 92.9‒96.9%), respectively. Patients receiving recanalization treatment (98%) had a better prognosis than those with a combined procedure (95.6%) and TIPS/DIPS treatment (94.5%). The systematic review and meta-analysis further solidify the role of endovascular intervention treatment in BCS as safe and effective. It maintains high technical and clinical success and long-term survival rates. The recanalization treatment had a better prognosis and outcome than the combined procedures and TIPS/DIPS treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
PRISMA flowchart of studies selection.
Figure 2
Figure 2
The Forest plot of technically success rate of intervention procedures in BCS patients, horizontal lines indicate 95% confidence intervals, square size indicates study specific statistical weight, and diamond indicates the overall treatment effect with 95% confidence intervals.
Figure 3
Figure 3
The Forest plot of clinically success rate after intervention treatment in BCS patients, horizontal lines indicate 95% confidence intervals, square size indicates study specific statistical weigh, and diamond indicates the overall treatment effect with 95% confidence intervals.
Figure 4
Figure 4
The Forest plot of the re-intervention rate after initial intervention procedures in BCS patients, horizontal lines indicate 95% confidence intervals, square size indicates study specific statistical weigh, and diamond indicates the overall treatment effect with 95% confidence intervals.
Figure 5
Figure 5
The Forest plot of the survival rate at 1 year after initial intervention procedures in BCS patients, horizontal lines indicate 95% confidence intervals, square size indicates study specific statistical weigh, and diamond indicates the overall treatment effect with 95% confidence intervals.
Figure 6
Figure 6
The Forest plot of the survival rate at 5 years after initial intervention procedures in BCS patients, horizontal lines indicate 95% confidence intervals, square size indicates study specific statistical weigh, and diamond indicates the overall treatment effect with 95% confidence intervals.

Similar articles

Cited by

References

    1. Valla DC. Primary Budd-Chiari syndrome. J. Hepatol. 2009;50(1):195–203. doi: 10.1016/j.jhep.2008.10.007. - DOI - PubMed
    1. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome: A review by an expert panel. J. Hepatol. 2003;38(3):364–371. doi: 10.1016/s0168-8278(02)00434-8. - DOI - PubMed
    1. Plessier A, Valla DC. Budd-Chiari syndrome. Semin. Liver Dis. 2008;28(3):259–269. doi: 10.1055/s-0028-1085094. - DOI - PubMed
    1. Riva N, Donadini MP, Dentali F, Squizzato A, Ageno W. Clinical approach to splanchnic vein thrombosis: risk factors and treatment. Thromb. Res. 2012;130(Suppl 1):S1–3. doi: 10.1016/j.thromres.2012.08.259. - DOI - PubMed
    1. Shetty S, Ghosh K. Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis–a concise review. Thromb. Res. 2011;127(6):505–512. doi: 10.1016/j.thromres.2010.09.019. - DOI - PubMed